AMGENPIPELINE.COM

Last Updated: May 15, 2024

AMGENPIPELINE.COM Summary

amgenpipeline.com has 4 NS records, 3 A records, 0 AAAA records, 1 MX records, and 0 TXT records. Name servers for amgenpipeline.com are ns-1645.awsdns-13.co.uk, ns-1084.awsdns-07.org, ns-72.awsdns-09.com, ns-536.awsdns-03.net. A records for amgenpipeline.com are 54.200.115.144, 35.155.1.101, 52.26.201.148. MX records that process @amgenpipeline.com email are amgen-com.mail.protection.outlook.com. We have observed amgenpipeline.com to have 14 subdomains. The domain's primary website is hosted on a awselb/2.0 web server at 54.213.178.45 in United States. The website's description is: "a robust pipeline leveraging state-of-the-art science and molecular engineering focused on the pursuit of transformative medicines with large effects in serious diseases. human genetic validation is used whenever possible to strengthen the evidence base for as many of our programs as possible." As of May 15, 2024, amgenpipeline.com does not have any threat intelligence reports of concern.

Search DigitalStakeout Footprint to find another asset.

AMGENPIPELINE.COM DNS Records

AAAA Records

No DNS AAAA records

TXT Records

No DNS TXT records

Search DigitalStakeout Footprint to find another asset.

AMGENPIPELINE.COM Subdomains

amgenpipeline.com has 14 subdomains in our inventory.

Hostname IP Address
amgenpipeline.com 54.200.115.144
cm.amgenpipeline.com 54.186.6.251
dev.cm.amgenpipeline.com 54.148.159.123
preview.amgenpipeline.com 44.230.15.127
uat.amgenpipeline.com 35.81.35.19
www.amgenpipeline.com 13.33.65.47
dev.amgenpipeline.com 52.26.228.142
uat.cm.amgenpipeline.com 34.211.218.146
alb-win-prod-3.amgenpipeline.com 52.40.160.169
alb-win-uat-01.amgenpipeline.com 34.213.53.57

Search DigitalStakeout Footprint to find another asset.

AMGENPIPELINE.COM Website

Web Server

awselb/2.0

IP Address

54.213.178.45

Country

United States

Meta Tags

og:description: a robust pipeline leveraging state-of-the-art science and molecular engineering focused on the pursuit of transformative medicines with large effects in serious diseases. human genetic validation is used whenever possible to strengthen the evidence base for as many of our programs as possible.

og:image: https://www.amgenpipeline.com/-/media/themes/amgen/amgenpipeline-com/amgenpipeline-com/images/desktop/pipeline/heroimage5.jpg

og:title: amgen pipeline

og:url: https://www.amgenpipeline.com

Search DigitalStakeout Footprint to find another asset.

AMGENPIPELINE.COM Certificate Trust

Certificate Trust Log

{"message_type": "certificate_update", "data": {"leaf_cert": {"not_after": 1725148799, "signature_algorithm": "sha256, rsa", "extensions": {"subjectKeyIdentifier": "08:65:41:7F:58:03:A9:5E:E7:DE:C6:DD:4C:3A:71:97:C2:EA:15:93", "authorityKeyIdentifier": "keyid:17:D9:D6:25:27:67:F9:31:C2:49:43:D9:30:36:44:8C:6C:A9:4F:EB\n", "extendedKeyUsage": "TLS Web server authentication, TLS Web client authentication", "subjectAltName": "DNS:www.amgenpipeline.com, DNS:uat.cm.amgenpipeline.com, DNS:uat.amgenpipeline.com, DNS:preview.amgenpipeline.com, DNS:dev.cm.amgenpipeline.com, DNS:dev.amgenpipeline.com, DNS:cm.amgenpipeline.com, DNS:amgenpipeline.com", "crlDistributionPoints": "Full Name:\n URI:http://crl.sectigo.com/SectigoRSAOrganizationValidationSecureServerCA.crl", "keyUsage": "Digital Signature, Key Encipherment", "certificatePolicies": "Policy: 2.23.140.1.2.2\nPolicy: 1.3.6.1.4.1.6449.1.2.1.3.4\n CPS: https://sectigo.com/CPS", "ctlPoisonByte": true, "authorityInfoAccess": "OCSP - URI:http://ocsp.sectigo.com\nCA Issuers - URI:http://crt.sectigo.com/SectigoRSAOrganizationValidationSecureServerCA.crt\n", "basicConstraints": "CA:FALSE"}, "fingerprint": "A9:10:53:8C:60:E5:A3:B5:9E:EB:95:50:B4:F9:EB:A1:A2:DC:12:6D", "all_domains": ["amgenpipeline.com", "cm.amgenpipeline.com", "dev.amgenpipeline.com", "dev.cm.amgenpipeline.com", "preview.amgenpipeline.com", "uat.amgenpipeline.com", "uat.cm.amgenpipeline.com", "www.amgenpipeline.com"], "serial_number": "ADFA7C4E9CB0947D6A7F461902796CB6", "subject": {"C": "US", "CN": "amgenpipeline.com", "L": null, "O": "Amgen Inc.", "ST": "California", "emailAddress": null, "OU": null, "aggregated": "/C=US/CN=amgenpipeline.com/O=Amgen Inc./ST=California"}, "not_before": 1693526400, "issuer": {"C": "GB", "CN": "Sectigo RSA Organization Validation Secure Server CA", "L": "Salford", "O": "Sectigo Limited", "ST": "Greater Manchester", "emailAddress": null, "OU": null, "aggregated": "/C=GB/CN=Sectigo RSA Organization Validation Secure Server CA/L=Salford/O=Sectigo Limited/ST=Greater Manchester"}}, "cert_link": "https://ct.googleapis.com/logs/us1/argon2024/ct/v1/get-entries?start=173082729&end=173082729", "source": {"url": "https://ct.googleapis.com/logs/us1/argon2024/", "name": "Google 'Argon2024' log"}, "update_type": "PrecertLogEntry", "seen": 1693554376.920417, "cert_index": 173082729}}

Search DigitalStakeout Footprint to find another asset.